课题基金 / 基金详情

A Randomized Phase III Trial of Preoperative Chemoradiotherapy vs Preoperative Chemotherapy for Resectable Gastric Cancer

A Randomized Phase III Trial of Preoperative Chemoradiotherapy vs Preoperative Chemotherapy for Resectable Gastric Cancer
可切除胃癌术前放化疗与术前化疗的随机 III 期试验
批准号:
238520
负责人:
O'Callaghan Christopher J
金额:
$123.18万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-09-01 至 2018-09-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
在加拿大,胃癌和食道癌分别是癌症死亡的第9和第10大原因。对于胃癌患者,手术可以治愈那些局部癌症,但大多数患者目前与更先进的癌症和治疗时,
英文摘要
In Canada, stomach and esophageal cancer are the 9th and 10th leading causes of cancer death respectively. For patients with stomach cancer, surgery may cure those with localized cancer, but most patients present with more advanced cancer and when treated
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金